^
Association details:
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Source:
Title:

Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy

Published date:
04/11/2022
Excerpt:
The aim of this study was to evaluate, as biomarkers, polymorphisms in genes...In patients treated with ifosfamide, ALDH1A1 rs3764435 was associated with RFS (p = 0.046)...In patients treated with ifosfamide, ALDH1A1 rs3764435 was associated with RFS (p = 0.046).
DOI:
10.3390/jpm12040618